AQP4 and myeloid sarcoma: Consequently, and given that many NMOSD cases are still initially misdiagnosed as MS, applying the 2015 NMOSD diagnostic criteria to both AQP4 seropositive and seronegative patients allows for more efficient detection of NMOSD (2, 23).